Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Puretech Health Plc ADR
(NQ:
PRTC
)
28.47
+0.50 (+1.79%)
Streaming Delayed Price
Updated: 10:45 AM EDT, May 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
294
Open
28.47
Bid (Size)
11.20 (2)
Ask (Size)
44.79 (1)
Prev. Close
27.97
Today's Range
28.47 - 28.47
52wk Range
17.08 - 34.00
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
PureTech Announces Annual Results for Year Ended December 31, 2023
April 25, 2024
From
PureTech Health plc
Via
Business Wire
PureTech Health: Notice of Results
April 18, 2024
From
PureTech Health plc
Via
Business Wire
Performance
YTD
+13.88%
+13.88%
1 Month
+1.86%
+1.86%
3 Month
+18.88%
+18.88%
6 Month
+42.64%
+42.64%
1 Year
+3.72%
+3.72%
More News
Read More
PureTech Announces Completion of Enrollment in Phase 2b ELEVATE IPF Trial of LYT-100 (Deupirfenidone) in Idiopathic Pulmonary Fibrosis
April 16, 2024
From
PureTech Health plc
Via
Business Wire
PureTech Receives FDA Fast Track Designation for LYT-200 in Head and Neck Cancers
April 11, 2024
From
PureTech Health plc
Via
Business Wire
PureTech Launches Seaport Therapeutics with $100 Million Oversubscribed Series A and Announces Management Transitions
April 09, 2024
From
PureTech Health plc
Via
Business Wire
PureTech Proposes $100 Million Capital Return
March 19, 2024
From
PureTech Health plc
Via
Business Wire
Bristol Myers Squibb Completes Acquisition of PureTech's Founded Entity Karuna Therapeutics for $14 Billion
March 18, 2024
From
PureTech Health plc
Via
Business Wire
PureTech Receives Orphan Drug Designation for LYT-200 in Acute Myeloid Leukemia
March 13, 2024
From
PureTech Health plc
Via
Business Wire
PureTech to Present at Two Upcoming Investor Conferences
February 27, 2024
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Akili Announces Positive Results from Shionogi’s Phase 3 Clinical Trial of Localized Version of Akili’s EndeavorRx ® for Pediatric ADHD Patients in Japan
February 27, 2024
From
PureTech Health plc
Via
Business Wire
PureTech to Present at 42nd Annual J.P. Morgan Healthcare Conference
January 03, 2024
From
PureTech Health plc
Via
Business Wire
Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
January 02, 2024
Via
Benzinga
Rivian Automotive Reports Weak Delivery Figures, Joins JOYY, MiMedx Group And Other Big Stocks Moving Lower On Tuesday
January 02, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Fisker Shares Are Trading Higher By Over 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session
December 29, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
December 25, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
December 22, 2023
Via
Benzinga
Why AAR Shares Are Trading Lower By 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
December 22, 2023
Via
Benzinga
Karuna Therapeutics Jumps Following Takeover By Bristol Myers, Joins Rocket Lab USA, Altair Engineering And Other Big Stocks Moving Higher On Friday
December 22, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
PureTech Founded Entity Karuna Therapeutics to be Acquired by Bristol Myers Squibb for $14 Billion
December 22, 2023
From
PureTech Health plc
Via
Business Wire
PureTech Year End Update and Outlook for 2024
December 20, 2023
From
PureTech Health plc
Via
Business Wire
ZimVie Agrees To Sell Its Spine Business, Joins United States Steel, PGT Innovations And Other Big Stocks Moving Higher On Monday
December 18, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
PureTech Presents Data from Phase 1 Trial of LYT-200 Targeting Galectin-9 in Solid Tumors at the ESMO Immuno-Oncology Congress 2023
December 07, 2023
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Karuna Therapeutics Announces U.S. Food and Drug Administration Accepts New Drug Application for KarXT for the Treatment of Schizophrenia
November 29, 2023
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Karuna Therapeutics Announces Positive Results from Phase 1b Ambulatory Blood Pressure Monitoring Trial of KarXT in Schizophrenia
November 17, 2023
From
PureTech Health plc
Via
Business Wire
PureTech's LYT-300 (Oral Allopregnanolone) Achieved Primary Endpoint in a Phase 2a Acute Anxiety Trial in Healthy Volunteers
November 14, 2023
From
PureTech Health plc
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.